Published in Clin Cancer Res on July 01, 2002
Molecular classification and correlates in colorectal cancer. J Mol Diagn (2007) 3.25
Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol (2010) 1.62
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay. BMC Cancer (2010) 1.38
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. J Clin Oncol (2011) 1.31
Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma. Cancer Res (2006) 1.24
Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer (2006) 1.22
Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch (2003) 1.15
Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn (2010) 0.93
The 5'-end transitional CpGs between the CpG islands and retroelements are hypomethylated in association with loss of heterozygosity in gastric cancers. BMC Cancer (2006) 0.88
Relationship between the extent of chromosomal losses and the pattern of CpG methylation in gastric carcinomas. J Korean Med Sci (2005) 0.88
Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Immunogenetics (2004) 0.85
Microsatellite instability in gastrointestinal tract cancers: a brief update. Surg Today (2005) 0.83
The gene-reduction effect of chromosomal losses detected in gastric cancers. BMC Gastroenterol (2010) 0.82
Establishing a biological profile for interval colorectal cancers. Dig Dis Sci (2014) 0.82
Characterizing the prevalence of chromosome instability in interval colorectal cancer. Neoplasia (2015) 0.81
Extensive and divergent chromosomal losses in squamous and spindle-cell components of esophageal sarcomatoid carcinoma. Virchows Arch (2003) 0.81
Gene expression variations in microsatellite stable and unstable colon cancer cells. J Surg Res (2011) 0.79
Copy number alterations and allelic ratio in relation to recurrence of rectal cancer. BMC Genomics (2015) 0.77
Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential. Br J Cancer (2004) 0.77
Are there tumor suppressor genes on chromosome 4p in sporadic colorectal carcinoma? World J Gastroenterol (2008) 0.76
Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma. World J Gastroenterol (2010) 0.75
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol (2011) 4.11
Low-level microsatellite instability in most colorectal carcinomas. Cancer Res (2002) 2.87
Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Am J Surg Pathol (2007) 2.02
Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol (2002) 1.82
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study. Cancer Res Treat (2012) 1.76
Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep (2011) 1.66
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology (2010) 1.55
Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch (2002) 1.51
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Identification of ROS1 rearrangement in gastric adenocarcinoma. Cancer (2013) 1.43
Filiform serrated adenoma is an unusual, less aggressive variant of traditional serrated adenoma. Pathology (2012) 1.42
The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput Biol (2007) 1.38
Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol (2008) 1.33
High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. PLoS One (2012) 1.32
Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer (2008) 1.28
The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour Biol (2012) 1.27
MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Mod Pathol (2013) 1.25
Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol (2005) 1.24
Polypoid arteriovenous malformation of colon mimicking inflammatory fibroid polyp. J Gastroenterol (2004) 1.23
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. J Korean Med Sci (2010) 1.21
Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers. Clin Cancer Res (2005) 1.21
Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch (2003) 1.15
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. Cancer Res Treat (2012) 1.14
Glomus tumor of the stomach: a clinicopathologic analysis of 10 cases and review of the literature. Gut Liver (2012) 1.12
High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations. PLoS One (2012) 1.09
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy. BMC Cancer (2011) 1.08
Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci (2010) 1.08
Transitional CpG methylation between promoters and retroelements of tissue-specific genes during human mesenchymal cell differentiation. J Cell Biochem (2007) 1.06
Small submucosal tumors of the stomach: differentiation of gastric schwannoma from gastrointestinal stromal tumor with CT. Korean J Radiol (2012) 1.04
Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea. Asia Pac J Clin Oncol (2011) 1.02
Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization. Gastroenterology (2006) 1.01
Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg (2008) 1.01
Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol (2010) 1.01
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas. Mod Pathol (2012) 1.00
Plexiform angiomyxoid myofibroblastic tumor of the stomach: report of two cases and review of the literature. Korean J Pathol (2012) 0.99
Gastric adenocarcinoma of fundic gland type: report of three cases. Korean J Pathol (2012) 0.98
P21-activated kinase 4 overexpression in metastatic gastric cancer patients. Transl Oncol (2011) 0.97
Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin Cancer Res (2008) 0.97
A hydrophobic ligand-binding protein of the Taenia solium metacestode mediates uptake of the host lipid: implication for the maintenance of parasitic cellular homeostasis. Proteomics (2007) 0.97
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS (2009) 0.97
GEAR: genomic enrichment analysis of regional DNA copy number changes. Bioinformatics (2007) 0.96
Composite glandular-endocrine cell carcinomas of the stomach: clinicopathologic and methylation study. APMIS (2005) 0.96
The length of CpG islands is associated with the distribution of Alu and L1 retroelements. Genomics (2006) 0.95
Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol (2007) 0.95
Critical roles for excretory-secretory cysteine proteases during tissue invasion of Paragonimus westermani newly excysted metacercariae. Cell Microbiol (2006) 0.95
Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas. Pathology (2012) 0.95
Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer. Ann Surg Oncol (2010) 0.95
Periodic explosive expansion of human retroelements associated with the evolution of the hominoid primate. J Korean Med Sci (2004) 0.94
HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. Int J Cancer (2014) 0.93
Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma. J Clin Invest (2014) 0.92
A large polypoid arteriovenous malformation of the colon treated with a detachable snare: case report and review of literature. Gastrointest Endosc (2005) 0.92
Microcystic/reticular schwannoma in the colon. Pathology (2009) 0.91
Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. J Surg Res (2008) 0.91
Genome-wide transcriptome profiling of ROS scavenging and signal transduction pathways in rice (Oryza sativa L.) in response to different types of ionizing radiation. Mol Biol Rep (2012) 0.90
Clinical significance of gastritis cystica profunda and its association with Epstein-Barr virus in gastric cancer. Cancer (2012) 0.90
A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers. PLoS One (2013) 0.90
DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Mod Pathol (2011) 0.89
Gastrointestinal stromal tumors in children and young adults: a clinicopathologic and molecular genetic study of 22 Korean cases. APMIS (2013) 0.89
Endoscopic submucosal dissection of early gastric cancer. Gut Liver (2011) 0.89
Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study. Acta Oncol (2011) 0.89
Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clin Cancer Res (2009) 0.89
Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol (2004) 0.88
Paralogous proteins comprising the 150 kDa hydrophobic-ligand-binding-protein complex of the Taenia solium metacestode have evolved non-overlapped binding affinities toward fatty acid analogs. Int J Parasitol (2011) 0.88
The 5'-end transitional CpGs between the CpG islands and retroelements are hypomethylated in association with loss of heterozygosity in gastric cancers. BMC Cancer (2006) 0.88
Inferring biological functions and associated transcriptional regulators using gene set expression coherence analysis. BMC Bioinformatics (2007) 0.88
Relationship between the extent of chromosomal losses and the pattern of CpG methylation in gastric carcinomas. J Korean Med Sci (2005) 0.88
A kinematic analysis of relative stability of the lower extremities between subjects with and without chronic low back pain. Eur Spine J (2011) 0.87
Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters. Korean J Pathol (2013) 0.87
The improvement of ginsenoside accumulation in Panax ginseng as a result of γ-irradiation. J Ginseng Res (2013) 0.86
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients. Invest New Drugs (2013) 0.86
A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages. Ann Surg Oncol (2012) 0.86
DNA methylation and expression patterns of key tissue-specific genes in adult stem cells and stomach tissues. J Korean Med Sci (2009) 0.86
Biochemical properties of a novel cysteine protease of Plasmodium vivax, vivapain-4. PLoS Negl Trop Dis (2010) 0.86
Helicobacter heilmannii-associated gastritis: clinicopathologic findings and comparison with Helicobacter pylori-associated gastritis. J Korean Med Sci (2007) 0.86
Melanotic neuroectodermal tumor of infancy disseminated by a ventriculoperitoneal shunt and diagnosed from the inguinal sac. J Pediatr Hematol Oncol (2014) 0.86
Clinical significance of tumor location in remnant gastric cancers developed after partial gastrectomy for primary gastric cancer. J Gastrointest Surg (2007) 0.86
Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene. PLoS One (2012) 0.86
Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer. Cancer Chemother Pharmacol (2011) 0.86
Preoperative predictive factors for gastrointestinal stromal tumors: analysis of 375 surgically resected gastric subepithelial tumors. J Gastrointest Surg (2014) 0.86
Esophageal lymphangiomatosis: a case report. Gastrointest Endosc (2002) 0.85
Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathol Int (2008) 0.85
Neuroendocrine tumor in gastric adenoma: a diagnostic pitfall mimicking invasive adenocarcinoma. Diagn Pathol (2012) 0.85
GAGE12 mediates human gastric carcinoma growth and metastasis. Int J Cancer (2014) 0.85
Vitellocyte-specific expression of phospholipid hydroperoxide glutathione peroxidases in Clonorchis sinensis. Int J Parasitol (2008) 0.85
Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity. Gastric Cancer (2014) 0.85
Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples. Korean J Pathol (2013) 0.85
Preoperative genetic diagnosis of gastric carcinoma based on chromosomal loss and microsatellite instability. Int J Cancer (2005) 0.85
Two-dimensional immunoblot analysis of antigenic proteins of Spirometra plerocercoid recognized by human patient sera. Parasitol Int (2011) 0.84
Management strategy for small duodenal carcinoid tumors: does conservative management with close follow-up represent an alternative to endoscopic treatment? Digestion (2013) 0.84
KIT amplification and gene mutations in acral/mucosal melanoma in Korea. APMIS (2011) 0.84
Endoscopic resection for undifferentiated early gastric cancer: focusing on histologic discrepancies between forceps biopsy-based and endoscopic resection specimen-based diagnosis. Dig Dis Sci (2014) 0.84
Endoscopic and histopathological characteristics suggesting the presence of gastric mucosal high grade neoplasia foci in cases initially diagnosed as gastric mucosal low grade neoplasia by forceps biopsy in Korea. J Gastroenterol (2010) 0.83
Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer. Breast Cancer Res Treat (2006) 0.83
Alu and L1 retroelements are correlated with the tissue extent and peak rate of gene expression, respectively. J Korean Med Sci (2004) 0.83
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab. Invest New Drugs (2014) 0.83
Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma. World J Gastroenterol (2013) 0.83
Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas. APMIS (2009) 0.83